Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer

References

• Perets R, Drapkin R. It’s totally tubular ….riding the new wave of ovarian cancer research. Cancer Res. 2016;76(1):10–17. doi:10.1158/0008-5472.CAN-15-138226669862
   PubMed Web of Science ®Google Scholar
• Vallius T, Hynninen J, Kemppainen J, et al. (18)F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer. Eur J Nucl Med Mol Imaging. 2018;45(7):1224–1232. doi:10.1007/s00259-018-3961-z29476227
   PubMedGoogle Scholar
• Ju X, Yu H, Liang D, et al. LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions. Biomed Pharmacother. 2018;102:549–554. doi:10.1016/j.biopha.2018.03.09229597088
   PubMed Web of Science ®Google Scholar
• Peng S, Li Z, Zou L, Liu W, Liu C, McClements DJ. Improving curcumin solubility and bioavailability by encapsulation in saponin-coated curcumin nanoparticles prepared using a simple pH-driven loading method. Food Funct. 2018;9(3):1829–1839. doi:10.1039/C7FO01814B29517797
   PubMed Web of Science ®Google Scholar
• Li W, Jiang Z, Xiao X, et al. Curcumin inhibits superoxide dismutase-induced epithelial-to-mesenchymal transition via the PI3K/Akt/NF-kappaB pathway in pancreatic cancer cells. Int J Oncol. 2018;52(5):1593–1602.
   PubMed Web of Science ®Google Scholar
• Sathe G, Pinto SM, Syed N, et al. Phosphotyrosine profiling of curcumin-induced signaling. Clin Proteomics. 2016;13:13. doi:10.1186/s12014-016-9114-027307780
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhao P, Wu S, et al. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. Int J Pharm. 2018;545(1–2):261–273. doi:10.1016/j.ijpharm.2018.05.00729730175
   PubMed Web of Science ®Google Scholar
• Ma L, Zhang X, Wang Z, et al. Anti-cancer effects of curcumin on myelodysplastic syndrome through the inhibition of enhancer of zeste homolog-2 (EZH2). Curr Cancer Drug Targets. 2019. doi:10.2174/1568009619666190212121735
   Web of Science ®Google Scholar
• Momtazi-Borojeni AA, Mosafer J, Nikfar B, et al. Curcumin in advancing treatment for gynecological cancers with developed drug- and radiotherapy-associated resistance. Rev Physiol Biochem Pharmacol. 2018;176:107–129.
   Web of Science ®Google Scholar
• Tomeh MA, Hadianamrei R, Zhao X. A review of curcumin and its derivatives as anticancer agents. Int J Mol Sci. 2019;20(5). doi:10.3390/ijms20051033
   PubMed Web of Science ®Google Scholar
• Kesharwani SS, Ahmad R, Bakkari MA, et al. Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): formulation development, characterization and pharmacological evaluation. J Control Release. 2018;290:165–179. doi:10.1016/j.jconrel.2018.08.00430142410
   PubMed Web of Science ®Google Scholar
• Kumar S, Kesharwani SS, Mathur H, Tyagi M, Bhat GJ, Tummala H. Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin. Eur J Pharm Sci. 2016;82:86–96. doi:10.1016/j.ejps.2015.11.01026588875
   PubMed Web of Science ®Google Scholar
• Kesharwani SS, Kaur S, Tummala H, Sangamwar AT. Overcoming multiple drug resistance in cancer using polymeric micelles. Expert Opin Drug Deliv. 2018;15(11):1127–1142. doi:10.1080/17425247.2018.153726130324813
   PubMed Web of Science ®Google Scholar
• Zhang M, Hagan CTT, Min Y, et al. Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models. Biomaterials. 2018;169:1–10. doi:10.1016/j.biomaterials.2018.03.05529631163
   PubMed Web of Science ®Google Scholar
• Kesharwani SS, Kaur S, Tummala H, Sangamwar AT. Multifunctional approaches utilizing polymeric micelles to circumvent multidrug resistant tumors. Colloids Surf B Biointerfaces. 2019;173:581–590. doi:10.1016/j.colsurfb.2018.10.02230352379
   PubMed Web of Science ®Google Scholar
• Zhao MD, Sun YM, Fu GF, et al. Gene therapy of endometriosis introduced by polymeric micelles with glycolipid-like structure. Biomaterials. 2012;33(2):634–643. doi:10.1016/j.biomaterials.2011.09.07721996531
   PubMedGoogle Scholar
• Tjhay F, Motohara T, Tayama S, et al. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer. Cancer Sci. 2015;106(10):1421–1428. doi:10.1111/cas.1276526250934
   PubMed Web of Science ®Google Scholar
• Wang J, He H, Xu X, Wang X, Chen Y, Yin L. Far-red light-mediated programmable anti-cancer gene delivery in cooperation with photodynamic therapy. Biomaterials. 2018;171:72–82. doi:10.1016/j.biomaterials.2018.04.02029680675
   PubMed Web of Science ®Google Scholar
• Zhao MD, Hu FQ, Du YZ, et al. Coadministration of glycolipid-like micelles loading cytotoxic drug with different action site for efficient cancer chemotherapy. Nanotechnology. 2009;20(5):055102. doi:10.1088/0957-4484/20/5/05510219417333
   PubMedGoogle Scholar
• Wang XJ, Peng CH, Zhang S, et al. Polysialic-acid-based micelles promote neural regeneration in spinal cord injury therapy. Nano Lett. 2019;19(2):829–838. doi:10.1021/acs.nanolett.8b0402030605619
   PubMed Web of Science ®Google Scholar
• Palma DA, Nguyen TK, Louie AV, et al. Measuring the integration of stereotactic ablative radiotherapy plus surgery for early-stage non-small cell lung cancer: a phase 2 clinical trial. JAMA ONCOL. 2019;5:681. doi:10.1001/jamaoncol.2018.699330789648
   PubMedGoogle Scholar
• Zehra B, Ahmed A, Sarwar R, et al. Apoptotic and antimetastatic activities of betulin isolated from quercus incana against non-small cell lung cancer cells. Cancer Manag Res. 2019;11:1667–1683. doi:10.2147/CMAR.S18695630863176
   PubMed Web of Science ®Google Scholar
• Shi SJ, Wang LJ, Han DH, et al. Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer. Theranostics. 2019;9(5):1247–1263. doi:10.7150/thno.2988430867828
   PubMedGoogle Scholar
• Wu D, Zhang Y, Xu X, et al. RGD/TAT-functionalized chitosan-graft-PEI-PEG gene nanovector for sustained delivery of NT-3 for potential application in neural regeneration. Acta Biomater. 2018;72:266–277. doi:10.1016/j.actbio.2018.03.03029578088
   PubMed Web of Science ®Google Scholar
• Andrade S, Ramalho MJ, Pereira MDC, Loureiro JA. Resveratrol brain delivery for neurological disorders prevention and treatment. Front Pharmacol. 2018;9:1261. doi:10.3389/fphar.2018.0126130524273
   PubMed Web of Science ®Google Scholar
• Que X, Su J, Guo P, et al. Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles. Drug Deliv. 2019;26(1):199–207. doi:10.1080/10717544.2019.157386130835586
   PubMed Web of Science ®Google Scholar
• Alsaab HO, Sau S, Alzhrani RM, et al. Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials. 2018;183:280–294. doi:10.1016/j.biomaterials.2018.08.05330179778
   PubMed Web of Science ®Google Scholar
• Li N, Liu YY, Li Y, et al. Fine tuning of emission behavior, self-assembly, anion sensing, and mitochondria targeting of pyridinium-functionalized tetraphenylethene by alkyl chain engineering. ACS Appl Mater Interfaces. 2018;10(28):24249–24257. doi:10.1021/acsami.8b0411329939714
   PubMedGoogle Scholar
• Wang W, Zhang K, Chen D. From tunable DNA/polymer self-assembly to tailorable and morphologically pure core-shell nanofibers. Langmuir. 2018;34(50):15350–15359. doi:10.1021/acs.langmuir.8b0299230427695
   PubMedGoogle Scholar
• Dong Q, Zhang H, Han Y, et al. Tumor environment differentiated “nanodepot” programmed for site-specific drug shuttling and combinative therapy on metastatic cancer. J Control Release. 2018;283:59–75. doi:10.1016/j.jconrel.2018.05.02729803613
   PubMedGoogle Scholar
• Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK. Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C Mater Biol Appl. 2019;98:1252–1276. doi:10.1016/j.msec.2019.01.06630813007
   PubMed Web of Science ®Google Scholar
• Liang C, Chao Y, Yi X, et al. Nanoparticle-mediated internal radioisotope therapy to locally increase the tumor vasculature permeability for synergistically improved cancer therapies. Biomaterials. 2019;197:368–379. doi:10.1016/j.biomaterials.2019.01.03330703742
   PubMedGoogle Scholar
• Wang Q, Zhong Y, Liu W, et al. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid. Drug Deliv. 2019;26(1):12–22. doi:10.1080/10717544.2018.150705730691317
   PubMed Web of Science ®Google Scholar
• Carvalho AM, Teixeira R, Novoa-Carballal R, Pires RA, Reis RL, Pashkuleva I. Redox-responsive micellar nanoparticles from glycosaminoglycans for CD44 targeted drug delivery. Biomacromolecules. 2018;19(7):2991–2999. doi:10.1021/acs.biomac.8b0056129758159
   PubMedGoogle Scholar
• Hossaini Nasr S, Tonson A, El-Dakdouki MH, et al. Effects of nanoprobe morphology on cellular binding and inflammatory responses: hyaluronan-conjugated magnetic nanoworms for magnetic resonance imaging of atherosclerotic plaques. ACS Appl Mater Interfaces. 2018;10(14):11495–11507. doi:10.1021/acsami.7b1970829558108
   PubMedGoogle Scholar
• Hu L, Li M, Zhang Z, Shen Y, Guo S. Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery. Int J Pharm. 2018;553(1–2):510–521. doi:10.1016/j.ijpharm.2018.10.01930308274
   PubMedGoogle Scholar
• Fratantonio D, Molonia MS, Bashllari R, et al. Curcumin potentiates the antitumor activity of Paclitaxel in rat glioma C6 cells, Phytomedicine: international. Phytomedicine. 2018;55:23–30. doi:10.1016/j.phymed.2018.08.00930668434
   PubMedGoogle Scholar
• Alemi A, Zavar Reza J, Haghiralsadat F, et al. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy. J Nanobiotechnology. 2018;16(1):28. doi:10.1186/s12951-018-0351-429571289
   PubMed Web of Science ®Google Scholar
• Yang Z, Sun N, Cheng R, et al. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells. Biomaterials. 2017;147:53–67. doi:10.1016/j.biomaterials.2017.09.01328930649
   PubMed Web of Science ®Google Scholar
• Yao Q, Gutierrez DC, Hoang NH, et al. Efficient codelivery of paclitaxel and curcumin by novel bottlebrush copolymer-based micelles. Mol Pharm. 2017;14(7):2378–2389. doi:10.1021/acs.molpharmaceut.7b0027828605595
   PubMed Web of Science ®Google Scholar
• Calaf GM, Ponce-Cusi R, Carrion F. Curcumin and paclitaxel induce cell death in breast cancer cell lines. Oncol Rep. 2018;40(4):2381–2388. doi:10.3892/or.2018.660330066930
   PubMedGoogle Scholar
• Gawde KA, Sau S, Tatiparti K, et al. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers. Colloids Surf B Biointerfaces. 2018;167:8–19. doi:10.1016/j.colsurfb.2018.03.04629625422
   PubMed Web of Science ®Google Scholar
• Zhao MD, Cheng JL, Yan JJ, et al. Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation. Int J Nanomedicine. 2016;11:1323–1336. doi:10.2147/IJN.S9969227099493
   PubMed Web of Science ®Google Scholar
• Biswas P, Mukhopadhyay A, Kabir SN, Mukhopadhyay PK. High-protein diet ameliorates arsenic-induced oxidative stress and antagonizes uterine apoptosis in rats. Biol Trace Elem Res. 2019;192:222–233. doi:10.1007/s12011-019-1657-230723882
   PubMedGoogle Scholar
• Camozzato GC, Martinez MN, Bastos HBA, et al. Ultrastructural and histological characteristics of the endometrium during early embryo development in mares. Theriogenology. 2019;123:1–10. doi:10.1016/j.theriogenology.2018.09.01830253251
   PubMedGoogle Scholar
• Zhou J, Li M, Lim WQ, et al. A transferrin-conjugated hollow nanoplatform for redox-controlled and targeted chemotherapy of tumor with reduced inflammatory reactions. Theranostics. 2018;8(2):518–532. doi:10.7150/thno.2119429290824
   PubMed Web of Science ®Google Scholar
• Zou H, Zhu J, Huang DS. Cell membrane capsule: a novel natural tool for antitumour drug delivery. Expert Opin Drug Deliv. 2019;16(3):1–19.30558447
   PubMed Web of Science ®Google Scholar
• Tang X, Wang G, Shi R, et al. Enhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticles. Drug Deliv. 2016;23(8):2686–2696. doi:10.3109/10717544.2015.104972026004129
   PubMed Web of Science ®Google Scholar
• Hattinger CM, Patrizio MP, Luppi S, Magagnoli F, Picci P, Serra M. Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatment. Expert Opin Drug Metab Toxicol. 2019;15:299–311. doi:10.1080/17425255.2019.158888530822170
   PubMed Web of Science ®Google Scholar